Yervoy | search
Click here to view Yervoy news from 60+ newspapers.
Bookmark or Share- YERVOY U.S. Prescribing Information - BMSYERVOY, in combination with nivolumab and 2 cycles of platinum-doublet chemotherapy, is indicated for the first-line treatment of adult patients with metastatic or recurrent NSCLC, with no EGFR or ALK genomic tumor aberrations.
- Yervoy: Uses, Dosage & Side Effects - Drugs.comWhat is Yervoy? Yervoy (ipilimumab) is a monoclonal antibody used to treat specific cancers including melanoma, non-small cell lung cancer (NSCLC), pleural mesothelioma, esophageal cancer, kidney cancer (RCC), liver cancer, or colorectal cancer. Yervoy can be used alone or combined with another cancer medicine such as Opdivo (nivolumab).
- Yervoy: Alternatives, side effects, cost, dosage, and moreYervoy (ipilimumab) is a prescription injection used to treat certain forms of cancer. Learn about alternatives, side effects, cost, dosage, and more.
- Ipilimumab - NCI - National Cancer Institute(ih-pih-LIH-myoo-mab) Ipilimumab is a type of targeted therapy drug called an immune checkpoint inhibitor (a type of immunotherapy). It is a monoclonal antibody that binds to the protein CTLA-4 on immune cells called T cells. It works by keeping cancer cells from suppressing the immune system.
- Ipilimumab - WikipediaIpilimumab, sold under the brand name Yervoy, is a monoclonal antibody medication that works to activate the immune system by targeting CTLA-4, a protein receptor that downregulates the immune system.
More
